Growth Metrics

Eli Lilly (LLY) Dividends Paid - Common (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.05%
Dec 31, 2025 0.02%
Sep 30, 2025 -0.16%
Jun 30, 2025 0.10%
Mar 31, 2025 15.25%
Dec 31, 2024 -0.22%
Sep 30, 2024 -0.16%
Jun 30, 2024 0.27%
Mar 31, 2024 14.88%
Dec 31, 2023 0.16%
Sep 30, 2023 -50.04%
Jun 30, 2023 99.96%
Mar 31, 2023 15.02%
Dec 31, 2022 0.25%
Sep 30, 2022 -50.04%
Jun 30, 2022 99.42%
Mar 31, 2022 14.51%
Dec 31, 2021 0.38%
Sep 30, 2021 -50.07%
Jun 30, 2021 99.14%
Mar 31, 2021 15.64%
Dec 31, 2020 -0.24%
Sep 30, 2020 -0.36%
Jun 30, 2020 0.40%
Mar 31, 2020 14.32%
Dec 31, 2019 -0.03%
Sep 30, 2019 -50.14%
Jun 30, 2019 84.89%
Mar 31, 2019 11.28%
Dec 31, 2018 0.00%
Sep 30, 2018 -1.16%
Jun 30, 2018 -1.36%
Mar 31, 2018 7.11%
Dec 31, 2017 0.11%
Sep 30, 2017 -0.18%
Jun 30, 2017 0.24%
Mar 31, 2017 1.16%
Dec 31, 2016 0.59%
Sep 30, 2016 -0.61%
Jun 30, 2016 0.54%
Mar 31, 2016 -0.68%
Dec 31, 2015 2.98%
Sep 30, 2015 -2.50%
Jun 30, 2015 2.25%
Mar 31, 2015 0.51%
Dec 31, 2014 0.04%
Sep 30, 2014 -0.36%
Jun 30, 2014 0.53%
Mar 31, 2014 2.56%
Dec 31, 2013 -3.16%
Sep 30, 2013 -0.99%
Jun 30, 2013 0.36%
Mar 31, 2013 -2.96%
Dec 31, 2012 0.57%
Sep 30, 2012 -1.13%
Jun 30, 2012 1.07%
Mar 31, 2012 0.13%
Dec 31, 2011 0.55%
Sep 30, 2011 -2.03%
Jun 30, 2011 1.64%
Mar 31, 2011 -0.17%
Dec 31, 2010 -0.22%
Sep 30, 2010 1.60%
Jun 30, 2010 -0.46%
Mar 31, 2010 -0.09%
Dec 31, 2009 0.58%
Sep 30, 2009 -0.45%
Jun 30, 2009 0.41%